STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Tropical Medicines Review Article

Nature’s Pharmacy: Plant-Based Antifungal Agents and Their Therapeutic Potential

  1. Ashish Yadav Department Of Pharmacy, Dasmesh College Of Pharmacy
  2. Himanshu Singh Department Of Pharmacy, Dasmesh College Of Pharmacy
  3. Rajkamal Department Of Pharmacy, Dasmesh College Of Pharmacy
  4. Nitish Kumar Department Of Pharmacy, Dasmesh College Of Pharmacy
  5. Raveena Rani Department Of Pharmacy, Dasmesh College Of Pharmacy

Abstract

Antifungal resistance has increased dramatically over the last 10 years, causing serious problems for healthcare because of higher morbidity and death. The urgent need for new treatments is highlighted by the scarcity of effective antifungal medications, their toxicity, and the rise of resistant strains. Since many plants have bioactive secondary metabolites with strong antifungal qualities, including alkaloids, flavonoids, terpenoids, phenolics, and saponins, ethnobotanical sources offer a viable path. Plants with notable antifungal action, such as Bridelia retusa, Hypoestes serpens, and Piper crassinervium, have been used in traditional medicine. These phytochemicals work by causing oxidative stress, blocking ergosterol synthesis, and rupturing fungal membranes. Recent developments in nanotechnology have improved the clinical potential of plant-derived chemicals by increasing their stability, bioavailability, and targeted delivery. Nevertheless, issues with bioavailability, standardization, and regulatory approval still exist. Finding safe, efficient, and long-lasting antifungal medicines to counteract growing resistance may be made easier by combining ethnobotanical knowledge with contemporary scientific study.

Keywords

References (79)

  1. Beck-Sague C, Banerjee S, Jarvis WR. Epidemiology of nosocomial infections. J Public Health.
  2. 1993;83:1739–45.
  3. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents
  4. Chemother. 1995;39(1):1–8.
  5. Jayasinghe L, Kumarihamy BMM, Jayarathna KHRN, Udishani NWMG, Bandara BMR, Hara N, et
  6. al. Antifungal constituents of the stem bark of Bridelia retusa. Phytochemistry. 2003;62(4):637–41.
  7. Ayurvedic Medicinal Plants Database. Available from: http://ayurvedicmedicinalplants.com. Accessed
  8. Singh UV, Ahlawat SP, Bisht NS. Nursery techniques of local tree species-II. SFRI Information Bulletin
  9. No. 11. Itanagar (India): State Forest Research Institute, Department of Environment and Forests,
  10. Government of Arunachal Pradesh; 2003. Available from: http://sfri.nic.in/pdf_files/Nursery%
  11. 20Techniques%20of %20Local%20Tree%20Species%20II.pdf.
  12. Borris RP. Natural products research: Perspectives from a major pharmaceutical company. J
  13. Ethnopharmacol. 1996;51(1–3):29–38.
  14. Lewis WH, Elvin-Lewis MP. Medicinal plants as sources of new therapeutics. Ann Mo Bot Gard.
  15. 1995;82:16–24.
  16. Schultes RE. The kingdom of plants. In: Thomson WAR, editor. Medicines from the Earth. New
  17. York: McGraw-Hill Book Company; 1978. p. 208.
  18. Jung HJ, Sung WS, Yeo SH, Kim HS, Lee IS, Woo ER, et al. Antifungal activity of plant extracts.
  19. Arch Pharm Res. 2006;29(9):746–51.
  20. Cafarchia C, De Laurentis N, Milillo MA, Losacco V, Puccini V. Antifungal activity of selected
  21. essential oils. Parassitologia. 2002;44:153–6.
  22. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564–82.
  23. Sunthitikawinsakul A, Kongkathip N, Kongkathip B, Phonnakhu S, Daly JW, Spande TF, et al.
  24. Bioactive alkaloids from medicinal plants. Planta Med. 2003;69:155–9.
  25. Reina M, Coloma AG, Díaz DD, Cabrera R, Mariño CG, Rodríguez ML, et al. Natural antifungal
  26. agents from medicinal plants. Nat Prod Res. 2006;20(1):13–19.
  27. Rahalison L, Benathan M, Monod M, Frenk E, Gupta MP, Solis PN, et al. Antifungal principles
  28. from medicinal plants. Planta Med. 1995;61(4):360–2.
  29. Chaurasia SC, Vyas KK. Antimicrobial studies of medicinal plants. J Res Indian Med Yoga
  30. Homeopathy. 1977;24:45–50.
  31. Shin S, Kang CA. Antifungal activity of plant essential oils. Lett Appl Microbiol. 2003;36(2):111–5.
  32. Belhouchet Z, Sautour M, Miyamoto T, Lacaille-Dubois MA. Antifungal saponins from plants.
  33. Chem Pharm Bull (Tokyo). 2008;56:1324–8.
  34. Escalante AM, Santecchia CB, Lopez SN, Gattuso MA, Gutierrez Ravelo A, Delle Monache A, et
  35. al. Antifungal activity of plant extracts. J Ethnopharmacol. 2002;82:29–34.
  36. Zhang JD, Cao YB, Xu Z, Sun HH, An MM, Yan L, et al. Antifungal properties of natural
  37. compounds. Biol Pharm Bull. 2005;28:2211–5.
  38. Wang F, Yang D, Ren S, Zhang H, Li R. Antifungal constituents from medicinal plants. J Chin
  39. Med Mater. 1999;22:400–4.
  40. Jayaweera DMA. Medicinal plants (indigenous and exotic) used in Ceylon. Part II. Colombo:
  41. National Science Council of Sri Lanka; 1982.
  42. Adhav M, Solanki CM, Patel B, Gharia A. Evaluation of isoflavanone as an antimicrobial agent
  43. from leaves of Bridelia retusa. Orient J Chem. 2002;18:Abstract 228.
  44. Mehare ID, Hatapakki BL. Antiinflammatory activity of bark of Bridelia retusa. Indian J Pharm
  45. Sci. 2003;65:410–1.
  46. Rasoamiaranjanahary L, Marston A, Guilet D, Schenk K, Randimbivololona F, Hostettmann K.
  47. Antifungal diterpenes from Hypoestes serpens. Phytochemistry. 2003;62:333–7.
  48. Rasoamiaranjanahary L, Guilet D, Marston A, Randimbivololona F, Hostettmann K. Antifungal
  49. isopimaranes from Hypoestes serpens. Phytochemistry. 2003;64:543–8.
  50. ZipcodeZoo Database. Hypoestes serpens plant information. Available from: http://zipcodezoo
  51. .com/Plants/H/Hypoestes_serpens.asp. Accessed May 2008.
  52. Andriamihaja B, Martin MT, Rasoanaivo P, Frappier F. A new diterpene from Hypoestes serpens.
  53. J Nat Prod. 2001;64:217–8.
  54. Yuncker TG. The Piperaceae of Brazil. Hoehnea. 1972;2:19–366.
  55. ZipcodeZoo Database. Piper crassinervium information. Available from: http://zipcodezoo.com
  56. /Plants/P/piper_crassinervium.asp. Accessed May 2008.
  57. Mabberley DJ. The Plant-Book: A portable dictionary of the higher plants. Cambridge: Cambridge
  58. University Press; 1997.
  59. Joly AB. Introdução à Taxonomia Vegetal. São Paulo: Editora Nacional; 1985.
  60. Yamaguchi LF, Lago JHG, Tanizaki TM, Mascio PD, Kato MJ. Antioxidant activity of compounds
  61. from Piper crassinervium. Phytochemistry. 2006;67:1838–43.
  62. Vallabhaneni S, Cleveland AA, Farley MM, et al. Epidemiology of echinocandin nonsusceptible
  63. Candida glabrata bloodstream infections. Open Forum Infect Dis. 2015;2(4):ofv163.
  64. Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus. Clin
  65. Infect Dis. 2016;62(3):362–8.
  66. Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Triazole resistance in
  67. Aspergillus species. J Fungi. 2016;2(3):21.
  68. Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in
  69. bloodstream infections. Indian J Med Res. 2012;136(6):997–1003.
  70. Nigussie D, Davey G, Tufa TB, Brewster M, Legesse BA, Fekadu A, et al. Antibacterial and antifungal
  71. activities of Ethiopian medicinal plants: A systematic review. Front Pharmacol. 2021;12:633921.
  72. Ko HS, Taguchi H, Takizawa K, Fukushima K, Kim HS. Enzymatic mechanisms in zygomycosis-
  73. causing Mucorales. Korean J Med Mycol. 2007;12(1):9–15.
  74. Chukwuebuka EO, Chukwuma OC, Obaje EG, Agbo UM, Okoye NC. Medicinal plants in
  75. antifungal drug discovery. J Med Imaging Infect. 2024;12(3):163.
  76. Zia Q, Khan AA, Zubair S, Owais M. Nanoformulated phytochemicals for antifungal therapy. J
  77. Neonatal Surg. 2025;14(2):2256.
  78. Kumar A. Plant-derived antifungal agents: challenges in clinical trials. J Asian Nat Prod Res.
  79. 2025;27(8):1–10.